MedPath

Predictive Model on the Effect of Lifestyles in the Management of T2D

Active, not recruiting
Conditions
Type 2 Diabetes
Interventions
Other: Standard care for T2D patients, Smartwatch
Registration Number
NCT05261841
Lead Sponsor
Casa Sollievo della Sofferenza IRCCS
Brief Summary

This study aims to produce new evidence on the positive effects of physical activity and certain individual lifestyles in the control of type 2 diabetic disease. The goal is to build and evaluate the effectiveness of a new parsimonious risk prediction model based on the use of classical variables (blood exams), already used in other models for predicting the risk related to the disease, together with measures obtained from the use of wearable devices (steps count, sleep hours, heart rate).

Detailed Description

Scientific literature has shown that the use of wearable devices can improve the control of type 2 diabetes mellitus. The aim of the study is to develop a statistical model for the control of type 2 diabetes mellitus (DMT2) based on the use of "conventional" clinical parameters and the use of "unconventional" data from wearable devices. The medical outcome variable that will be used to measure diabetes control and model performance will be the Glycated Hemoglobin (HbA1c). The participant will receive a Samsung smartwatch (Galaxy Watch 3) and a Samsung smartphone (A51), (the latter only in case the participant is not in possession of a compatible smartphone) which he/she must wear during his daily activities and also during the night to measure daily activity, sleep hours and heart rate. Casa Sollievo della Sofferenza Hospital previoulsy developted the ENFORCE calculator, an inexpensive and parsimonious prediction model of 2-year all cause mortality in real life patients with T2D. In this study the investigators aim to elaborate a standardized validated risk scores similar to what has been done for ENFORCE.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Age ≥ 55 years old
  • Affected by Type 2 Diabetes and monitored by Casa Sollievo della Sofferenza Hospital
  • Basic skills in using a smartphone and its apps
  • Available to use the device and its applications
  • Ability to understand the informed consent
Exclusion Criteria
  • Inability to understand the informed consent
  • Low life expectancy
  • Type 1 Diabetes
  • Secondary Diabetes

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
TYPE 2 DIABETESStandard care for T2D patients, SmartwatchPatients affected by type 2 diabetes
Primary Outcome Measures
NameTimeMethod
Change from Baseline HbA1c at 6 and 12 monthsBaseline, 6 months, 12 months

Glycated Hemoglobin

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Casa Sollievo della Sofferenza IRCCS

🇮🇹

San Giovanni Rotondo, FG, Italy

© Copyright 2025. All Rights Reserved by MedPath